Jeffrey Bland
Jeffrey Bland is a researcher and practitioner working in the fields of functional, integrative, and personalized lifestyle medicine. His published research focuses on functional nutrition, metabolic health, and the effects of dietary supplements and polyphenols on immune function and biological markers. He also writes on the evolution of healthcare paradigms, including nutrition education in medical schools and personalized wellness interventions.
21 claims checked on air: 5 context 3 contradicted 2 overstated 3 supported 8 unverified
What they said on air - context
3 citing their own research
Tartary buckwheat contains over 150 different immune-active phytochemicals.
"It has over 150 different immune-active uh phytochemicals, plant-derived uh substances." (said at 0:15:01)
Comprehensive metabolomic profiling of Tartary buckwheat (Fagopyrum tataricum) has identified hundreds of secondary metabolites and phytochemicals, including numerous flavonoids, phenolic acids, anthraquinones, fagopyritols, and triterpenoids. Broad classes of these compounds exhibit anti-inflammatory, antioxidant, and immunomodulatory activities in preclinical models, and Tartary buckwheat concentrates have shown effects on immune-related gene pathways and epigenetic clocks in preliminary human trials. However, the designation of 'over 150 immune-active' compounds reflects untargeted metabolomic detection of phytochemical constituents rather than 150 individually characterized and clinically validated human immune-modulating agents.
- supports: Phytochemical and Pharmacological Profiles of Three Fagopyrum Buckwheats. (International journal of molecular sciences 2016) · cited 129x in the literature
"A total of 106 compounds isolated from three Fagopyrum buckwheats can be mainly divided into six classes: flavonoids, phenolics, fagopyritols, triterpenoids, steroids and fatty acids... Considerable pharmacological experiments both in vitro and in vivo have validated that Fagopyrum buckwheats possess antitumor, anti-oxidant, anti-inflammatory, hepatoprotective, anti-diabetic activities, etc." (abstract, results)
pubmedfull study (doi) - context: Rewiring of the seed metabolome during Tartary buckwheat domestication. (Plant biotechnology journal 2023) · cited 64x in the literature
"The comprehensive profiling of 200 Tartary buckwheat accessions exhibits 540 metabolites modified as a consequence of human selection." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The impact of a polyphenol-rich supplement on epigenetic and cellular markers of immune ag… (Frontiers in nutrition 2024) · cited 17x in the literature
"Analysis revealed significant intervention-related changes in multiple epigenetic age clocks and immune markers as well as population-wide alterations in gene ontology (GO) pathways related to longevity and immunity." (abstract, results, passage verified)
pubmedfull study (doi)
Tartary buckwheat is a 4,000-year-old food crop that was lost in America a couple hundred years ago.
"tartary buckwheat, which is a 4,000-year-old food product that was lost in America a couple hundred years ago" (said at 0:15:01)
The speaker's statement about Tartary buckwheat (*Fagopyrum tataricum*) is partially supported by agricultural genomics and historical evidence, but needs historical context. Genomic and archaeobotanical research confirms that Tartary buckwheat has been cultivated for approximately 4,000 years, originating in southwest and northern China before spreading globally. However, the crop is not native to the Americas; it was introduced to North America by European settlers in the colonial era (17th–18th centuries). Buckwheat cultivation in the United States and Canada did decline dramatically, but this occurred primarily over the late 19th and early 20th centuries (with the rise of industrialized cereal crops and synthetic fertilizers), rather than being an ancient American crop 'lost a couple hundred years ago.'
In a 50-person clinical trial, supplementation for 90 days with Himalayan Tartary Buckwheat polyphenols reduced participants' epigenetic immune age by 47%.
"in which we found in 50 individuals that those individuals who consumed the the matrix of these polyphenols found in Himalayan Tartary Buckwheat who started off with an aged immune system and we can measure that looking at the epigenetic age using various age algorithms uh that after 90 days of supplementation lo and behold it lowered their immune age by 47%." (said at 0:31:19)
The speaker accurately describes the results of an open-label, single-arm pilot clinical trial (PMID 39628466) involving 50 participants who consumed a Himalayan Tartary Buckwheat polyphenol supplement for 90 days. In that study, epigenetic clock algorithms were used to estimate biological and immune age, reporting reductions in epigenetic immune age, particularly among participants exhibiting accelerated baseline immune aging. However, context is needed because the study lacked a placebo or control group, was exploratory in design, and commercial epigenetic clocks serve as proxy biomarkers rather than direct clinical outcomes.
In a study of healthy individuals, consuming Himalayan Tartary Buckwheat concentrate for 90 days modulated approximately 30% of genes via epigenetic remodeling.
"in our study uh with Himalayan Tartary Buckwheat in apparently healthy people we found that something on the order of 30% of their uh genes were modulated in the epigenetic remodeling by consuming 90 days of our of our Himalayan Tartary Buckwheat concentrate." (said at 0:36:45)
A 90-day open-label pilot clinical trial in 50 healthy adults (aged 18–85 years) evaluated a standardized polyphenol concentrate derived from Tartary buckwheat (Fagopyrum tataricum). The study reported significant intervention-related changes across epigenetic age clocks, immune cell subsets, and gene ontology pathways linked to longevity and immune function. However, the trial was a small, uncontrolled pilot study, meaning findings represent preliminary exploratory signals rather than definitive evidence of systemic epigenetic remodeling.
Sprouting Tartary Buckwheat under a 450 nanometer light spectrum at neutral pH in sterile conditions yields threefold higher phytochemical levels than the flour.
"We find that 450 nanometers is the best spectrum that then activates within four days in a neutral pH in a sterile situation the sprouts to have threefold the level of phytochemicals as they would have in the flour itself." (said at 0:38:40)
Research on Tartary buckwheat (*Fagopyrum tataricum*) sprouts demonstrates that exposure to blue light (such as blue LED lighting) enhances the accumulation of phenylpropanoid compounds, flavonoids, and overall phenolics compared to red light or standard dark germination conditions. Specifically, maximum accumulation of rutin and key biosynthetic gene expressions in Tartary buckwheat sprouts are observed around 4 days after exposure to blue LED light. However, while sprouting under blue LED light significantly enhances phenolic and flavonoid content compared to non-germinated seeds or seeds grown under other light conditions, the claim that sprouting under 450 nm light at neutral pH in sterile conditions yields exactly threefold higher phytochemical levels specifically compared to Tartary buckwheat flour oversimplifies the quantitative variation reported across studies, which depends heavily on the specific phytochemical, cultivation parameters, and baseline flour measurements.
Fact-checked episodes
Publications
- Artificial Intelligence-Artificial Wisdom Medicine, Meaning, and the Impact of Artificial Intelligence.Integrative medicine (Encinitas, Calif.) 2026 · CEBM Level 5
- Nutrition Education in Medical School: What Should It Include?Integrative medicine (Encinitas, Calif.) 2026 · CEBM Level 5
- A proposal to "Whole" our knowing: Clinical medicine in the Noosphere.Explore (New York, N.Y.) 2025 · CEBM Level 5
- The Paradigm-Shifting Future of Health Care: Rise of Predictive, Personalized Lifestyle Medicine.Integrative medicine (Encinitas, Calif.) 2025 · CEBM Level 5
- Treating Metabolic Syndrome: P4 Medicine Meets Functional Medicine.Phenomics (Cham, Switzerland) 2025 · CEBM Level 5
- The impact of a polyphenol-rich supplement on epigenetic and cellular markers of immune age: a pilot clinical study.Frontiers in nutrition 2024 · CEBM Level 4
- LIFEHOUSE's Functional Nutrition Examination (Physical Exam, Anthropometrics, and Selected Biomarkers) Informs Personalized Wellness Interventions.Journal of personalized medicine 2023 · CEBM Level 4
- Personalized Lifestyle Intervention and Functional Evaluation Health Outcomes SurvEy: Presentation of the LIFEHOUSE Study Using N-of-One Tent-Umbrella-Bucket Design.Journal of personalized medicine 2022 · CEBM Level 5
- Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine.Nutrients 2022 · CEBM Level 5
- Clinical Understanding of the Sleep-Immune Connection.Integrative medicine (Encinitas, Calif.) 2022 · CEBM Level 5
- Functional Medicine Past, Present, and Future .Integrative medicine (Encinitas, Calif.) 2022 · CEBM Level 5
- Our Healing Journey: Restoring Connection, Finding Hope and Evolving Wellness.Integrative medicine (Encinitas, Calif.) 2022 · CEBM Level 5
- Therapeutic Use of Omega-3 Fatty Acids for Immune Disorders In Search of the Ideal Omega-3 Supplement .Integrative medicine (Encinitas, Calif.) 2022 · CEBM Level 5
- Glutathione, Orthomolecular Medicine, and Nutraceutical Therapy.Integrative medicine (Encinitas, Calif.) 2022 · CEBM Level 5
- Why the Pegan Diet Makes Sense.Integrative medicine (Encinitas, Calif.) 2021 · CEBM Level 5
- COVID-19 Risk: Clinical Tools for Assessing and Personalizing Immunity.Integrative medicine (Encinitas, Calif.) 2021 · CEBM Level 5
- A Discovery that Reframes the Whole of Global Healthcare in the 21st Century: The Importance of the Imprintome.Integrative medicine (Encinitas, Calif.) 2021 · CEBM Level 5
- Application of Phytochemicals in Immune Disorders: Their Roles Beyond Antioxidants.Integrative medicine (Encinitas, Calif.) 2021 · CEBM Level 5
- Prostate Cancer Risk Connection to Immunity, Hormones, and the Microbiome.Integrative medicine (Encinitas, Calif.) 2021 · CEBM Level 5
- Spaceship Earth Revisited: The Co-Benefits of Overcoming Biological Extinction of Experience at the Level of Person, Place and Planet.International journal of environmental research and public health 2020 · CEBM Level 5
- What is the Best Way to Assess Functional Health?: The History of the Development and Application of the Patient Reported Outcome Measurement Information System (PROMIS).Integrative medicine (Encinitas, Calif.) 2020 · CEBM Level 5
- Reflections on the COVID-19 Pandemic.Integrative medicine (Encinitas, Calif.) 2020 · CEBM Level 5
- The Long Haul of COVID-19 Recovery: Immune Rejuvenation versus Immune Support.Integrative medicine (Encinitas, Calif.) 2020 · CEBM Level 5
- Bitter Taste Receptor Ligand Improves Metabolic and Reproductive Functions in a Murine Model of PCOS.Endocrinology 2019 · CEBM Level 5
- Fasting Physiology and Therapeutic Diets: A Look Back to the Future.Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- The Dark Matter of Nutrition: Dietary Signals Beyond Traditional Nutrients .Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- Eighth Annual Conference of inVIVO Planetary Health: From Challenges to Opportunities.International journal of environmental research and public health 2019 · CEBM Level 5
- What is Evidence-Based Functional Medicine in the 21st Century?Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- Linus Pauling (1901-1994).Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- In Defense of Direct-to-Consumer Genetic Testing.Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- Systems Biology Meets Functional Medicine.Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- Notes from a Functional Medicine Watcher.Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- The Evolution of Personalized Nutrition-From Addis, Pauling, and RJ Williams to the Future.Integrative medicine (Encinitas, Calif.) 2019 · CEBM Level 5
- Intestinal bitter taste receptor activation alters hormone secretion and imparts metabolic benefits.Molecular metabolism 2018 · CEBM Level 5
- The Natural Roots of Functional Medicine.Integrative medicine (Encinitas, Calif.) 2018 · CEBM Level 5
- Age-related Disease: A Revolution Is Coming.Integrative medicine (Encinitas, Calif.) 2018 · CEBM Level 5
- Age-related Disease: A Revolution is Coming, Part 2-Dietary Acid Load, Hypertension, and Cardiovascular Disease.Integrative medicine (Encinitas, Calif.) 2018 · CEBM Level 5
- Age as a Modifiable Risk Factor for Chronic Disease.Integrative medicine (Encinitas, Calif.) 2018 · CEBM Level 5
- Making Genetic Testing More Clinically Valuable.Integrative medicine (Encinitas, Calif.) 2018 · CEBM Level 5
- Creating Health in America, One Person at a Time: A Message for Incoming President Trump.Integrative medicine (Encinitas, Calif.) 2017 · CEBM Level 5
- Defining Function in the Functional Medicine Model.Integrative medicine (Encinitas, Calif.) 2017 · CEBM Level 5
- The Influence of a KDT501, a Novel Isohumulone, on Adipocyte Function in Humans.Frontiers in endocrinology 2017 · CEBM Level 4
- Effects of KDT501 on Metabolic Parameters in Insulin-Resistant Prediabetic Humans.Journal of the Endocrine Society 2017 · CEBM Level 4
- Cardiac Lymphatics: An Example of Systems Biology in Medicine.Integrative medicine (Encinitas, Calif.) 2017 · CEBM Level 5
- Chronic Fatigue Syndrome, Functional Mitochondriopathy, and Enterohepatic Dysfunction.Integrative medicine (Encinitas, Calif.) 2017 · CEBM Level 5
- Cardiology Meets Personalized Lifestyle Medicine.Integrative medicine (Encinitas, Calif.) 2017 · CEBM Level 5
- When Is a Rare Disease Not so Rare? Implications for Medical Nutrition Therapy.Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- Mild Cognitive Impairment, Neurodegeneration, and Personalized Lifestyle Medicine.Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- Where Is Health Care Headed?Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- The Gut Mucosal Firewall and Functional Medicine.Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- Intestinal Microbiome, Akkermansia muciniphila , and Medical Nutrition Therapy.Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- Kidney Disease: Personalized Lifestyle Health Care Makes a Big Difference.Integrative medicine (Encinitas, Calif.) 2016 · CEBM Level 5
- Functional Medicine: An Operating System for Integrative Medicine.Integrative medicine (Encinitas, Calif.) 2015 · CEBM Level 5
- When Is a Disease a "Disease"?Integrative medicine (Encinitas, Calif.) 2015 · CEBM Level 5
- KDT501, a derivative from hops, normalizes glucose metabolism and body weight in rodent models of diabetes.PloS one 2014 · CEBM Level 5
- META060 protects against diet-induced obesity and insulin resistance in a high-fat-diet fed mouse.Nutrition (Burbank, Los Angeles County, Calif.) 2013 · CEBM Level 5
- Personalized lifestyle medicine: relevance for nutrition and lifestyle recommendations.TheScientificWorldJournal 2013 · CEBM Level 5
- Jeffrey Bland, Phd, FACN, FACB: heart disease, inflammation, and the revolution in health care. Interview by Craig Gustafson.Alternative therapies in health and medicine 2013 · CEBM Level 5
- META060 attenuates TNF-α-activated inflammation, endothelial-monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP-1 in THP-1 monocytes.Atherosclerosis 2012 · CEBM Level 5
- Isolation of bitter acids from hops (Humulus lupulus L.) using countercurrent chromatography.Journal of separation science 2012 · CEBM Level 5
- Optimized mixture of hops rho iso-alpha acids-rich extract and acacia proanthocyanidins-rich extract reduces insulin resistance in 3T3-L1 adipocytes and improves glucose and insulin control in db/db mice.Nutrition research and practice 2012 · CEBM Level 5
- The Heart and Medicine: Exploring the Interconnectedness of Cardiometabolic-related Concerns Through a Systems Biology Approach.Global advances in health and medicine 2012 · CEBM Level 5
- The Effects of Tetrahydro-iso-alpha Acids and Niacin on Monocyte-Edothelial Cell Interactions and Flow-mediated Vasodilation.Global advances in health and medicine 2012 · CEBM Level 2
- Nutritional supplementation of hop rho iso-alpha acids, berberine, vitamin D₃, and vitamin K₁ produces a favorable bone biomarker profile supporting healthy bone metabolism in postmenopausal women with metabolic syndrome.Nutrition research (New York, N.Y.) 2011 · CEBM Level 2
- A program consisting of a phytonutrient-rich medical food and an elimination diet ameliorated fibromyalgia symptoms and promoted toxic-element detoxification in a pilot trial.Alternative therapies in health and medicine 2011 · CEBM Level 3
- Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial.Journal of bone and mineral metabolism 2010 · CEBM Level 2
- META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.Arthritis and rheumatism 2010 · CEBM Level 5
- Cancers as systemic functional diseases, Part 2: clinical implications.Alternative therapies in health and medicine 2010 · CEBM Level 5
- Antidiabetic screening of commercial botanical products in 3T3-L1 adipocytes and db/db mice.Journal of medicinal food 2010 · CEBM Level 5
- Hop and Acacia Phytochemicals Decreased Lipotoxicity in 3T3-L1 Adipocytes, db/db Mice, and Individuals with Metabolic Syndrome.Journal of nutrition and metabolism 2010 · CEBM Level 2
- Subjects with elevated LDL cholesterol and metabolic syndrome benefit from supplementation with soy protein, phytosterols, hops rho iso-alpha acids, and Acacia nilotica proanthocyanidins.Journal of clinical lipidology 2010 · CEBM Level 2
- A science-based, clinically tested dietary approach for the metabolic syndrome.Metabolic syndrome and related disorders 2009 · CEBM Level 5
- Rho iso-alpha acids from hops inhibit the GSK-3/NF-kappaB pathway and reduce inflammatory markers associated with bone and cartilage degradation.Journal of inflammation (London, England) 2009 · CEBM Level 5
- Functional somatic syndromes, stress pathologies, and epigenetics.Alternative therapies in health and medicine 2008 · CEBM Level 5
- Does complementary and alternative medicine represent only placebo therapies?Alternative therapies in health and medicine 2008 · CEBM Level 5
- Systems biology, functional medicine, and folates.Alternative therapies in health and medicine 2008 · CEBM Level 5
- The importance of functional biomarkers in the management of chronic illness.Alternative therapies in health and medicine 2008 · CEBM Level 5
- Dietary management of the metabolic syndrome beyond macronutrients.Nutrition reviews 2008 · CEBM Level 5
- The future of nutritional pharmacology.Alternative therapies in health and medicine 2008 · CEBM Level 5
- Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial.Nutrition & metabolism 2008 · CEBM Level 2
- Autism: asking the right questions to find the right answers.Alternative therapies in health and medicine 2008 · CEBM Level 5
- Managing biotransformation: introduction and overview.Alternative therapies in health and medicine 2007 · CEBM Level 5
- A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals.Nutrition reviews 2007 · CEBM Level 5
- Acid-alkaline balance: role in chronic disease and detoxification.Alternative therapies in health and medicine 2007 · CEBM Level 5
- Clinical safety and efficacy of NG440: a novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditions.Canadian journal of physiology and pharmacology 2007 · CEBM Level 2
- Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women.Nutrition (Burbank, Los Angeles County, Calif.) 2006 · CEBM Level 2
- Alternative therapies--a moving target.Alternative therapies in health and medicine 2005 · CEBM Level 5
- Clinical effects of a proprietary combination isoflavone nutritional supplement in menopausal women: a pilot trial.Alternative therapies in health and medicine 2005 · CEBM Level 4
- A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia.Phytotherapy research : PTR 2005 · CEBM Level 4
- Biomarkers of aging: from primitive organisms to humans.The journals of gerontology. Series A, Biological sciences and medical sciences 2004 · CEBM Level 5
- Jeffrey S. Bland, PhD, FACN, CNS: functional medicine pioneer.Alternative therapies in health and medicine 2004 · CEBM Level 5